tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Zelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
Company AnnouncementsZelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
6d ago
Zelira Therapeutics Advances HOPE® Program with Secured FDA Trial Funding
PremiumCompany Announcements
Zelira Therapeutics Advances HOPE® Program with Secured FDA Trial Funding
25d ago
Zelira Therapeutics Secures Fourth Funding Tranche to Advance FDA Trials
PremiumCompany Announcements
Zelira Therapeutics Secures Fourth Funding Tranche to Advance FDA Trials
27d ago
Zelira Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Zelira Therapeutics Announces Change in Director’s Interest
1M ago
Zelira Therapeutics Issues Convertible Notes
PremiumCompany Announcements
Zelira Therapeutics Issues Convertible Notes
2M ago
Zelira Therapeutics Issues 3.5 Million Convertible Notes
PremiumCompany AnnouncementsZelira Therapeutics Issues 3.5 Million Convertible Notes
2M ago
Zelira Therapeutics Unveils Growth Plans at Investment Conference
Premium
Company Announcements
Zelira Therapeutics Unveils Growth Plans at Investment Conference
3M ago
Zelira Therapeutics Secures Shareholder Support at AGM
Premium
Company Announcements
Zelira Therapeutics Secures Shareholder Support at AGM
3M ago
Zelira Therapeutics Prepares for 2024 Shareholders Meeting
PremiumCompany Announcements
Zelira Therapeutics Prepares for 2024 Shareholders Meeting
3M ago
Zelira Therapeutics’ Financials: Borrowings Boost Cash Flow
PremiumCompany Announcements
Zelira Therapeutics’ Financials: Borrowings Boost Cash Flow
4M ago
Zelira Therapeutics Advances in FDA Trials and Product Development
PremiumCompany Announcements
Zelira Therapeutics Advances in FDA Trials and Product Development
4M ago
Zelira Therapeutics Schedules Hybrid 2024 AGM
PremiumCompany Announcements
Zelira Therapeutics Schedules Hybrid 2024 AGM
5M ago
Zelira Therapeutics Announces Upcoming AGM
PremiumCompany AnnouncementsZelira Therapeutics Announces Upcoming AGM
5M ago
Zelira Therapeutics Eyes FDA Approval for HOPE® 1
Premium
Company Announcements
Zelira Therapeutics Eyes FDA Approval for HOPE® 1
5M ago
Zelira Therapeutics Updates on FDA Progress
Premium
Company Announcements
Zelira Therapeutics Updates on FDA Progress
5M ago
Zelira Therapeutics Sets AGM and Expands Product Reach
PremiumCompany Announcements
Zelira Therapeutics Sets AGM and Expands Product Reach
5M ago
Zelira Therapeutics Upholds Strong Corporate Governance
PremiumCompany Announcements
Zelira Therapeutics Upholds Strong Corporate Governance
6M ago
Zelira Therapeutics Reports Sharp Increase in Losses
PremiumCompany Announcements
Zelira Therapeutics Reports Sharp Increase in Losses
6M ago
Zelira Therapeutics Advances Autism Drug Program
PremiumCompany Announcements
Zelira Therapeutics Advances Autism Drug Program
6M ago
Zelira Therapeutics Advances with HOPE® Trials
PremiumCompany AnnouncementsZelira Therapeutics Advances with HOPE® Trials
7M ago
Zelira Therapeutics Gains Momentum with FDA
Premium
Company Announcements
Zelira Therapeutics Gains Momentum with FDA
8M ago
Zelira Therapeutics Boosts Capital with Chairman’s Loan
Premium
Company Announcements
Zelira Therapeutics Boosts Capital with Chairman’s Loan
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >